County
Lake Emergency Medical System
The current listed document is more than 24 months old and may be outdated.
Drugs and doses35
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride6
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | page 200 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 172, 173 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 200 |
| SVT | adult | 6 mg | IV | not captured | standing | pages 66, 67, 172, 173, 200 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 66, 67, 172, 173, 200 |
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | pages 66, 67 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 201 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 201 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 89 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 177 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | pages 68, 70, 71, 202 |
| Other | adult | 150 mg | IV | not captured | standing | pages 173, 202 |
| Other | peds | 5 mg/kg | IV | not captured | standing | pages 173, 202 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 70, 71, 173, 202 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 70, 71, 173, 202 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 58, 59, 198, 203 |
| Other | adult | 324 mg | not captured | not captured | standing | page 203 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | pages 63, 170, 171, 204 |
| Bradycardia | adult | 1 mg | IV | not captured | standing | pages 62, 63 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 63, 170, 171, 204 |
| Organophosphate poisoning | adult | 2–4 mg | not captured | not captured | standing | page 94 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 94, 146, 147, 204 |
| Other | adult | 0.5 mg | IV/IO | not captured | standing | page 204 |
| Other | adult | 0.5 mg | not captured | not captured | standing | page 204 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 204 |
| Other | peds | 0.02 mg/kg | not captured | not captured | standing | page 204 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 206 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 206 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 60, 61, 68, 70, 166, 167, 206 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 166, 167, 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 60, 61 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 94 |
| Other | adult | 1 g | IV | not captured | standing | page 206 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 206 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 206 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 206 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Fentanyl7
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | peds | 5 mL/kg | IV | not captured | standing | page 170 |
| Cardiac arrest | adult | 25 g | IV | not captured | standing | page 208 |
| Hypoglycemia | adult | 2.5 mL/kg | IV | not captured | standing | page 208 |
| Hypoglycemia | adult | 2.5 mL/kg | IV | not captured | standing | page 97 |
| Hypoglycemia | peds | 5 mL/kg | IV | not captured | standing | pages 96, 180 |
| Hypoglycemia | peds | 5 mL/kg | IV | not captured | standing | page 208 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.4 mL | PR | not captured | standing | page 320 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
| Other | adult | 10 mg | IV | not captured | standing | pages 66, 67 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 209 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 209 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 209 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 209 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 88 |
| Other | adult | 1 mg/kg | IV/IM | not captured | standing | page 89 |
| Other | adult | 1 mg/kg | IV/IM | not captured | standing | page 105 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | page 209 |
| Other | adult | 25 mg | IV/IM | not captured | standing | page 84 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 209 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 177 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5 mcg/kg | IV | not captured | standing | page 210 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 210 |
| Hypotension / shock | peds | 1–5 mcg/kg | IV/IO | not captured | standing | page 210 |
| Hypotension / shock | peds | 1–5 mcg/kg | IV | not captured | standing | page 210 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–8 mcg | IV | not captured | standing | page 211 |
| Other | adult | 0.3–0.5 mg | IM | not captured | standing | page 211 |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 82, 184, 211 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | pages 82, 184, 211 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 211 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 211 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 211 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 0.5 mcg/kg | IV | not captured | standing | pages 78, 79 |
G–L Glucagon, Haloperidol, Hydroxocobalamin, Ipratropium, Ketamine, Labetalol, Lidocaine, Lorazepam8
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 213 |
| Hypoglycemia | adult | 1 mg | not captured | not captured | standing | page 213 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 213 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 213 |
| Other | adult | 0.5 mg | not captured | not captured | standing | page 213 |
| Other | adult | 1 mg | IV | not captured | standing | page 87 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 213 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 179, 213 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 105 |
| Other | adult | 2.5–5 mg | IM | not captured | standing | page 105 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 76 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 205 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 205 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 205 |
| COPD | peds | 0.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 205 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 89 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 177 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–2 mg/kg | IV/IO | not captured | standing | page 187 |
| Other | adult | 1–2 mg/kg | IV/IO | not captured | standing | pages 78, 79 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 267 |
| Other | adult | 60 mg | not captured | not captured | standing | page 322 |
| Other | peds | 0.5–2 mg/kg | IV/IO | not captured | standing | page 187 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | pages 186, 187, 322 |
| Post-intubation sedation | adult | 1–2 mg/kg | IV | not captured | standing | pages 78, 79 |
| Procedural sedation | adult | 2 mg/kg | not captured | not captured | standing | page 215 |
| Procedural sedation | peds | 2 mg/kg | not captured | not captured | standing | page 215 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 78, 79, 215 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 78, 79, 215 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | pages 98, 99, 154, 155, 216 |
| Other | adult | 5 mg | IV | not captured | standing | pages 98, 99, 216 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | pages 218, 279, 280 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 218, 279, 280 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Agitation | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Status epilepticus | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Status epilepticus | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose9
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 154, 155, 219 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 154, 155, 219 |
| Eclampsia / pre-eclampsia | adult | 4–5 g | IV | not captured | standing | pages 154, 155, 219 |
| Other | adult | 1–2 g | IV | not captured | standing | pages 82, 83, 219 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 82, 83, 219 |
| Other | peds | 25–75 mg/kg | IV | not captured | standing | pages 82, 83, 219 |
| Other | peds | 25–75 mg/kg | IV/IO | not captured | standing | pages 82, 83, 219 |
| VF / pulseless VT | adult | 1–2 g | IV | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
| VF / pulseless VT | peds | 50 mg/kg | IV | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV | not captured | standing | pages 88, 89, 176, 177, 228 |
| Allergic reaction | peds | 2 mg/kg | IV | not captured | standing | pages 88, 89, 176, 177, 228 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | pages 82, 83, 184, 185, 228 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | pages 82, 83, 184, 185, 228 |
| COPD | adult | 125 mg | IV | not captured | standing | pages 82, 83, 228 |
| COPD | peds | 2 mg/kg | IV | not captured | standing | pages 82, 83, 228 |
| Other | adult | 125 mg | IV/IM | not captured | standing | page 228 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | page 176 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | page 228 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV | not captured | standing | page 65 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 72 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 71 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 107 |
| Other | adult | 5 mg | IM | not captured | standing | page 72 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 187 |
| Other | peds | 0.1 mg/kg | not captured | not captured | standing | page 187 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 188 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 220 |
| Other | peds | 0.2 mg/kg | IM | not captured | standing | page 188 |
| Post-intubation sedation | adult | 2.5–5 mg | IV | not captured | standing | pages 78, 79 |
| Post-intubation sedation | adult | 2.5–5 mg | IV | not captured | standing | pages 68, 72, 78, 187 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV | not captured | standing | pages 68, 72, 78, 187 |
| Procedural sedation | adult | 2.5 mg | IV | not captured | standing | page 63 |
| Procedural sedation | adult | 2.5 mg | IV | not captured | standing | pages 66, 67 |
| RSI induction | adult | 5 mg | IV | not captured | standing | pages 79, 187 |
| Seizure | adult | 2.5–5 mg | IM | not captured | standing | page 220 |
| Seizure | adult | 5–15 mg | IV | not captured | standing | page 220 |
| Seizure | adult | 5–15 mg | IV/IM | not captured | standing | pages 106, 107, 188, 189, 220 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 220 |
| Seizure | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 106, 107, 188, 189, 220 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 220 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Burns | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV | not captured | standing | page 221 |
| Opioid overdose | adult | 0.5 mg | IM | not captured | standing | pages 90, 94, 95, 166 |
| Opioid overdose | adult | 0.5 mg | IV | not captured | standing | pages 90, 94, 95, 166 |
| Opioid overdose | adult | 0.5 mg | not captured | not captured | standing | page 94 |
| Opioid overdose | peds | 0.1 mg/kg | IM | not captured | standing | pages 90, 94, 95, 166 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | pages 90, 94, 95, 166 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 94 |
| Other | adult | 0.5 mg | IV/IM | not captured | standing | page 90 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 103 |
| Other | adult | 0.5 mg | IV/IM | not captured | standing | page 95 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 166, 167 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 58, 222 |
| CHF / pulmonary edema | adult | 0.4 mg | ODT | not captured | standing | page 82 |
| Other | adult | 0.4 mg | ODT | not captured | standing | page 58 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 10 mcg | IV | not captured | standing | pages 59, 62, 63, 64, 65, 72, 73, 82, 109, 113, 191, 217 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV | not captured | standing | pages 59, 62, 63, 64, 65, 72, 73, 82, 109, 113, 191, 217 |
| Other | adult | 10 mcg | IV | not captured | standing | pages 62, 63 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM/ODT | not captured | standing | page 231 |
| Nausea / vomiting | adult | 4 mg | IV/IM/ODT | not captured | standing | page 231 |
| Nausea / vomiting | peds | 2 mg | IV/IM/ODT | not captured | standing | page 231 |
| Nausea / vomiting | peds | 2 mg | IV/IM/ODT | not captured | standing | page 231 |
| Nausea / vomiting | peds | 4 mg | IV/IM/ODT | not captured | standing | page 231 |
| Nausea / vomiting | peds | 4 mg | IV/IM/ODT | not captured | standing | page 231 |
| Other | adult | 4 mg | IV/IM/ODT | not captured | standing | page 84 |
| Other | adult | 4 mg | IV | not captured | standing | page 85 |
| Other | adult | 4 mg | IV/ODT | not captured | standing | page 86 |
| Other | adult | 4 mg | IM/ODT | not captured | standing | pages 98, 99 |
| Other | adult | 4 mg | IV/IM/ODT | not captured | standing | page 58 |
| Mild to moderate pain | adult | 4 mg | IM/ODT | not captured | standing | page 103 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–45 g | PO | not captured | standing | page 223 |
| Hypoglycemia | peds | 5–45 g | PO | not captured | standing | page 223 |
P–R Pralidoxime, Rocuronium2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | page 147 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 79, 225 |
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 79 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 79, 225 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 123, 166, 167 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 123, 166, 167 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 226 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 60, 61 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 226 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 94, 226 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 94, 226 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg/kg | not captured | not captured | standing | page 229 |
| Other | peds | 2 mg/kg | not captured | not captured | standing | page 229 |
| RSI induction | adult | 100 mg | IV | not captured | standing | pages 79, 268 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | page 230 |
| Other | adult | 1 g | IV | not captured | standing | page 230 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 230 |
| Trauma / hemorrhage | peds | 1000 mg | IV | not captured | standing | page 230 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 230 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 230 |
Cite this
Lake Emergency Medical System, United States EMS Protocol Census. 222 dose entries, effective 2022-03-01.
https://protoquiz.com/census/agencies/lake-emergency-medical-system/
The census is free and not for sale. Only public agencies are named.